[HTML][HTML] Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
T Haraguchi, M Tsujimoto, Y Kashima, K Sato… - CVIR …, 2024 - Springer
Background The clinical implications of restenosis after drug-coated balloon (DCB)
treatment remain unclear. We compared the clinical outcomes between DCB angioplasty for …
treatment remain unclear. We compared the clinical outcomes between DCB angioplasty for …
[HTML][HTML] Drug-Coated Balloon Angioplasty in Pulmonary Vein Stenosis: A Promising Tool
J Ghobrial - Case Reports, 2023 - jacc.org
Pulmonary vein stenosis (PVS) is a rare condition that is either congenital or acquired and
carries a high risk of morbidity and mortality. Depending on the severity of stenosis and …
carries a high risk of morbidity and mortality. Depending on the severity of stenosis and …
Is Drug-Coated Balloon the Real Winner for Femoropopliteal Artery Intervention?
F Liistro - Cardiovascular Interventions, 2023 - jacc.org
During the last decades, endovascular treatment of femoropopliteal (FP) artery disease
showed a significant innovative escalation from conventional balloon angioplasty (PTA) and …
showed a significant innovative escalation from conventional balloon angioplasty (PTA) and …